LSP is one of Europe’s largest and most experienced healthcare investment firms. With a track record going back more than 25 years, we have built up an investment house that is dedicated to only one task: seeking, nurturing and growing healthcare investment opportunities with the potential to have a positive impact on society. We believe such opportunities create the most value for all parties. From our offices in Amsterdam, Munich and Boston, our team aims to back the smartest inventors with the best ideas. While their goal is to develop products and technologies that have a positive impact on society, our objective is to help inventors achieve their goals. By definition, success is often accompanied by financial returns. The combination of contributing to society and the prospect of associated financial returns is why investors entrust LSP to invest their capital
LSP
Claim instruction:
- Send us an email to claim@startus.cc from an official LSP email account. The content must be:
StartUs buddies,
Please, allow me to claim rights over LSP.
Best regards,
[your name] - Once sent the email click the Claim Startup button.
- Our team will verify the origin account and will grant claim rights over the startup to the user if everything is ok.
Our LSP V fund was launched in late 2014 (here is the press release). It is the successor fund to our previous closed-end investment funds that we have raised over the past 15 years. Through the years, we have stuck to the same and proven investment strategy and focus. LSP V, just like its predecessors, targets investments in healthcare companies developing novel and ground-breaking products and technologies that provide solutions to unmet medical needs. This strategy and focus has paved the way for LSP to become one of Europe’s foremost names in healthcare investing.
Our LSP Health Economics Fund (LSP HEF) was launched in 2012. At its start, it received a €50 million cornerstone investment from Achmea, the largest healthcare insurance company in The Netherlands. This was soon followed by an investment by another large strategic investor called Menzis and later by a number of large family offices and other (semi-) institutional investors. The fund’s strategy is to invest in late-stage private healthcare companies that have products on the market or are very close to market introduction. Contrary to our other funds, the LSP HEF Fund does not invest in companies that develop drugs.
Contact:
Login or register to see the contact information!
Address information
